Blog

A team of researchers at Daegu Gyeongbuk Institute of Science & Technology in Korea created a centrifugal system to separate circulating tumor cells from blood samples. Resembling a DVD, the device separates the cells using the centrifugal force created when it is spun. A layer of white blood cells and circulating tumor cells is formed during the spinning process and then antibody-studded magnetic beads bind and remove the white blood cells, leaving the circulating tumor cells in the final sample.

With the FDA’s nod, Lensar will begin rolling out the Ally adaptive cataract treatment system in a small-scale initial launch in the third quarter.

Read the full article at: www.fiercebiotech.com

Digital diagnostics may speed up autism diagnoses, which can be even further delayed for girls and for kids from low-income and nonwhite families.

Read the full article at: www.fiercebiotech.com

Ablative Solutions has raised $91.4 million for a device to target nerves known to influence the body’s regulation of blood pressure.

Read the full article at: www.mddionline.com

Illumina discovered cybersecurity flaws in some of its genetic sequencing software, potentially opening a door for hackers to access health data.

Read the full article at: www.fiercebiotech.com

Too many cooks in the kitchen spoil the broth, but medtech developers are betting that adding more tech to the OR will only improve success rates.

Read the full article at: www.fiercebiotech.com

A partnership between C2i Genomics and Karkinos Healthcare will enable whole-genome-sequencing minimal residual disease (MRD) cancer testing in India.

Read the full article at: www.mddionline.com

In the latest advancements of AI and med tech, the Eko DUO stands out as a smart and reliable product with FDA-cleared artificial intelligence (AI) algorithms being used to detect leading indicators of heart disease. More significantly, this is a smart stethoscope that boasts point-of-care ECG capabilities to detect signs of heart disease such as murmurs and arrhythmias, making it truly unique in its class and one of the first of its kind being used in the clinic. 

Read the full article at: www.medgadget.com

Blood pressure is a crucial factor in cardiovascular health, but measuring it using conventional pressurized cuff systems in a doctor’s clinic is prone to unreliable results. A one-off measurement merely offers a clinician with one snapshot in time, potentially missing an intermittent issue. However, patients can also be prone to “white coat syndrome,” where anxiety during such measurements can lead to significantly misleading results. Continuous measurements are preferable, but pressure cuff-based systems are cumbersome and inconvenient to wear on the move. This has inspired cuffless monitors, but some of these, such as optical systems, are prone to accuracy issues. Vivalink, a medtech company based in California, has created a cuffless blood pressure patch that the company reports is less prone to such issues. 

Read the full article at: www.medgadget.com

Medtronic’s deal to purchase Acutus Medical’s entire range of left-heart access devices just got a bit sweeter.

Read the full article at: www.fiercebiotech.com